TrialMedical oncology (Northwood, London, England)2013

Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience.

Lorenzo Livi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.